Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
   D02 EMOLLIENTS AND PROTECTIVES
   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D05 ANTIPSORIATICS
   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
     D06A ANTIBIOTICS FOR TOPICAL USE
     D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
       D06BA Sulfonamides
       D06BB Antivirals
         D06BB01 Idoxuridine
         D06BB02 Tromantadine [DG:DG00405]
         D06BB03 Aciclovir [DG:DG00406]
         D06BB04 Podophyllotoxin
         D06BB05 Inosine [DG:DG00407]
         D06BB06 Penciclovir [DG:DG00408]
         D06BB07 Lysozyme [DG:DG00409]
           D08152  Lysozyme (DCF)
           D03332  Lysozyme hydrochloride (JP17) <JP>
         D06BB08 Ibacitabine
         D06BB09 Edoxudine
         D06BB10 Imiquimod
         D06BB11 Docosanol
         D06BB12 Sinecatechins
         D06BB53 Aciclovir, combinations
       D06BX Other chemotherapeutics
     D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS
   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
   D08 ANTISEPTICS AND DISINFECTANTS
   D09 MEDICATED DRESSINGS
   D10 ANTI-ACNE PREPARATIONS
   D11 OTHER DERMATOLOGICAL PREPARATIONS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
     J05A DIRECT ACTING ANTIVIRALS
       J05AA Thiosemicarbazones
       J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
       J05AC Cyclic amines
       J05AD Phosphonic acid derivatives
       J05AE Protease inhibitors [DG:DG01647]
       J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
       J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
       J05AH Neuraminidase inhibitors [DG:DG02842]
       J05AJ Integrase inhibitors [DG:DG03135]
       J05AP Antivirals for treatment of HCV infections
       J05AR Antivirals for treatment of HIV infections, combinations
       J05AX Other antivirals
         J05AX01 Moroxydine
         J05AX02 Lysozyme [DG:DG00409]
           D08152  Lysozyme (DCF)
           D03332  Lysozyme hydrochloride (JP17) <JP>
         J05AX05 Inosine pranobex
         J05AX06 Pleconaril
         J05AX07 Enfuvirtide
         J05AX09 Maraviroc
         J05AX10 Maribavir
         J05AX13 Umifenovir
         J05AX17 Enisamium iodide
         J05AX18 Letermovir
         J05AX19 Tilorone
         J05AX21 Pentanedioic acid imidazolyl ethanamide
         J05AX23 Ibalizumab
         J05AX24 Tecovirimat [DG:03049]
         J05AX25 Baloxavir marboxil
         J05AX26 Amenamevir
         J05AX27 Favipiravir
         J05AX28 Bulevirtide [DG:DG03116]
         J05AX29 Fostemsavir [DG:DG03096]
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 14, 2020
According to WHO's ATC 2021

» Japanese version